Group Company 2024 2023 2024 2023 RM’000 RM’000 RM’000 RM’000 CASH FLOWS FROM OPERATING ACTIVITIES (CONTINUED) Balance brought forward 1,510,614 1,207,086 849,837 137,777 Adjustments for (continued): Gain on liquidation of a subsidiary – (786) – – Loss on disposal of subsidiaries – 2,234 – – Realisation of foreign exchange loss upon liquidation of a subsidiary – 970 – – Realisation of foreign exchange loss upon disposal of subsidiaries – 6,362 – – Loss on disposal of biological assets 895 1,014 – – Biological asset written off 343 79 – – Reversal of impairment loss on receivables (net) (1,855) (2,733) – – Inventories written off 9,535 5,136 – – Allowance for inventories obsolescence 6,948 5,230 – – Share of results from associates 1,903 1,498 – – Share of results from joint ventures (31,681) (24,836) – – Net unrealised foreign exchange (gain)/loss (3,992) 2,668 (463) 294 Dividends from subsidiaries – – (945,292) (199,756) Dividend income from financial assets at fair value through other comprehensive income (3,739) (3,258) – – Finance costs 136,057 125,154 97,847 84,443 Finance income (42,255) (35,123) (3,246) (1,141) Other losses, net 403,724 108,738 – – Fair value changes in biological assets (net) (42,343) 25,885 – – Provision for defined benefit plan 7,575 17,837 142 384 Termination of lease contracts (net) (2,261) 299 – – Provision for asset retirement 4,984 – – – Unwinding of discount for provision for asset retirement 372 418 – – Operating profit before working capital changes 1,954,824 1,443,872 (1,175) 22,001 Statements of Cash Flows For the financial year ended 31 December 2024 21
RkJQdWJsaXNoZXIy NDgzMzc=